We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Marc is a trained neuroscientist with 30 years of experience using patch clamp and imaging techniques to study ion channel function and modulation. He was an early adopter of automated patch clamp platforms for ion channel screening and has an excellent knowledge of this market and extensive connections with users and vendors. Marc co-founded several ion channel companies, before setting up his consultancy company Albion Drug Discovery Services.
Marc Rogers, Metrion Biosciences, outlines the benefits of targeting ion channels for pain and some of the hurdles in developing successful ion channel modulators.
Marc is a trained neuroscientist with 30 years of experience using patch clamp and imaging techniques to study ion channel function and modulation. He was an early adopter of automated patch clamp platforms for ion channel screening and has an excellent knowledge of this market and extensive connections with users and vendors. Marc co-founded several ion channel companies, before setting up his consultancy company Albion Drug Discovery Services.